Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc. annual/quarterly revenue history and growth rate from 2022 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

• Unicycive Therapeutics Inc. revenue for the quarter ending March 31, 2023 was 675000.
• Unicycive Therapeutics Inc. annual revenue for 2023 was 675000, a 29.02% decrease from 2022.
• Unicycive Therapeutics Inc. annual revenue for 2022 was 951000.